NCT06446154 2024-12-31Fruquintinib After ICIs Treatment in Unresectable Hepatocellular CarcinomaSun Yat-sen UniversityPhase 2 Recruiting36 enrolled
NCT05971199 2023-08-02Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular CarcinomaZhejiang Cancer HospitalPhase 2 Unknown27 enrolled